{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:34:38Z","timestamp":1770741278916,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["P23021"],"award-info":[{"award-number":["P23021"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006546","name":"Angelini Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainstimjrnl.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.brs.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T22:45:42Z","timestamp":1551134742000},"page":"1041-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression"],"prefix":"10.1016","volume":"12","author":[{"given":"Thomas","family":"Vanicek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg S.","family":"Kranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Vyssoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Fugger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkadiusz","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"H\u00f6flich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertraud","family":"Saumer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergej","family":"Milovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4641-9539","authenticated-orcid":false,"given":"Rupert","family":"Lanzenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.brs.2019.02.015_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur Neuropsychopharmacol: J. Eur. College of Neuropsychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.brs.2019.02.015_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jad.2011.07.027","article-title":"Phenomenology of psychotic mood disorders: lifetime and major depressive episode features","volume":"135","author":"Souery","year":"2011","journal-title":"J\u00a0Affect Disord"},{"issue":"9904","key":"10.1016\/j.brs.2019.02.015_bib3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.brs.2019.02.015_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/15622975.2014.1001786","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015","volume":"16","author":"Bauer","year":"2015","journal-title":"World J Biol Psychiatr: Off. J. World Feder. Soc. Biol. Psychiatr."},{"issue":"9360","key":"10.1016\/j.brs.2019.02.015_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"UK ECT Review Group","year":"2003","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.brs.2019.02.015_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jad.2004.05.006","article-title":"Electroconvulsive therapy in depressive illness that has not responded to drug treatment","volume":"83","author":"Husain","year":"2004","journal-title":"J\u00a0Affect Disord"},{"issue":"4","key":"10.1016\/j.brs.2019.02.015_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4088\/JCP.v65n0406","article-title":"Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report","volume":"65","author":"Husain","year":"2004","journal-title":"J\u00a0Clin Psychiatr"},{"issue":"1","key":"10.1016\/j.brs.2019.02.015_bib8","first-page":"13","article-title":"Efficacy of ECT in depression: a meta-analytic review","volume":"20","author":"Pagnin","year":"2004","journal-title":"J\u00a0ECT"},{"issue":"2","key":"10.1016\/j.brs.2019.02.015_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.brs.2015.01.354","article-title":"Antidepressant effects of ECT may be related to hippocampal neurogenesis","volume":"8","author":"Loo","year":"2015","journal-title":"Brain Stimulation: Basic, Trans. Clin. Res. Neuromodulation"},{"key":"10.1016\/j.brs.2019.02.015_bib10","first-page":"1","article-title":"Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis","author":"Gryglewski","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.brs.2019.02.015_bib11","first-page":"116","article-title":"Neurotransmitters and electroconvulsive therapy","volume":"30","author":"Baldinger","year":"2014","journal-title":"J\u00a0ECT"},{"issue":"1","key":"10.1016\/j.brs.2019.02.015_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/mp.2012.93","article-title":"Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET","volume":"18","author":"Lanzenberger","year":"2013","journal-title":"Mol Psychiatr"},{"issue":"Pt B","key":"10.1016\/j.brs.2019.02.015_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castren","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.brs.2019.02.015_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/mp.2013.10","article-title":"BDNF: an indicator of insomnia?","volume":"19","author":"Giese","year":"2014","journal-title":"Mol Psychiatr"},{"issue":"4","key":"10.1016\/j.brs.2019.02.015_bib15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.brs.2018.04.003","article-title":"Electroconvulsive seizures influence dendritic spine morphology and BDNF expression in a neuroendocrine model of depression","volume":"11","author":"Maynard","year":"2018","journal-title":"Brain Stimulation: Basic, Trans. Clin. Res. Neuromodulation"},{"issue":"5","key":"10.1016\/j.brs.2019.02.015_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/dneu.20758","article-title":"The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity","volume":"70","author":"Castren","year":"2010","journal-title":"Develop. Neurobiol."},{"issue":"2","key":"10.1016\/j.brs.2019.02.015_bib17","first-page":"121","article-title":"The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression","volume":"26","author":"Hu","year":"2010","journal-title":"J\u00a0ECT"},{"issue":"5","key":"10.1016\/j.brs.2019.02.015_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/15622975.2014.892633","article-title":"BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis","volume":"15","author":"Brunoni","year":"2014","journal-title":"World J Biol Psychiatr: Off. J. World Feder. Soc. Biol. Psychiatr."},{"key":"10.1016\/j.brs.2019.02.015_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bjorkholm","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.brs.2019.02.015_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.brs.2019.02.015_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.biopsych.2008.08.035","article-title":"Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide","volume":"65","author":"Dwivedi","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.brs.2019.02.015_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresbull.2016.02.013","article-title":"Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF)","volume":"121","author":"Freire","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.brs.2019.02.015_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major\u00a0depressive disorder: a meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J\u00a0Psychiatr Res"},{"issue":"11","key":"10.1016\/j.brs.2019.02.015_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141564","article-title":"Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: systematic review and meta-analyses of the preclinical and clinical literature","volume":"10","author":"Polyakova","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.brs.2019.02.015_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/13651501003748560","article-title":"A\u00a0close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers","volume":"14","author":"Yoshimura","year":"2010","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.brs.2019.02.015_bib26","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1038\/srep17989","article-title":"A\u00a0method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays","volume":"5","author":"Polacchini","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.brs.2019.02.015_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"Karege","year":"2002","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.brs.2019.02.015_bib28","first-page":"195","article-title":"Efficacy of continuation\/maintenance electroconvulsive therapy for the prevention of recurrence of a major depressive episode in adults with unipolar depression: a systematic review","volume":"30","author":"Brown","year":"2014","journal-title":"J\u00a0ECT"},{"issue":"2","key":"10.1016\/j.brs.2019.02.015_bib29","first-page":"86","article-title":"Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial","volume":"29","author":"Nordenskjold","year":"2013","journal-title":"J\u00a0ECT"},{"issue":"9","key":"10.1016\/j.brs.2019.02.015_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s001150170045","article-title":"[Use of electroconvulsive therapy in psychiatry]","volume":"72","author":"Frey","year":"2001","journal-title":"Nervenarzt"},{"key":"10.1016\/j.brs.2019.02.015_bib31","series-title":"The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American psychiatric association","first-page":"355","author":"Association AP","year":"2001"},{"issue":"5","key":"10.1016\/j.brs.2019.02.015_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archpsyc.57.5.425","article-title":"A\u00a0prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities","volume":"57","author":"Sackeim","year":"2000","journal-title":"Arch Gen Psychiatr"},{"issue":"3","key":"10.1016\/j.brs.2019.02.015_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00406-014-0543-3","article-title":"Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients","volume":"265","author":"Bumb","year":"2015","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"10.1016\/j.brs.2019.02.015_bib34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.euroneuro.2006.04.010","article-title":"Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients","volume":"16","author":"Bocchio-Chiavetto","year":"2006","journal-title":"Eur Neuropsychopharmacol: J. Eur. College of Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.brs.2019.02.015_bib35","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.pnpbp.2008.02.009","article-title":"Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study","volume":"32","author":"Okamoto","year":"2008","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"issue":"5","key":"10.1016\/j.brs.2019.02.015_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.euroneuro.2009.01.002","article-title":"Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy","volume":"19","author":"Piccinni","year":"2009","journal-title":"Eur Neuropsychopharmacol: J. Eur. College of Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.brs.2019.02.015_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1224162","article-title":"Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats","volume":"42","author":"Sartorius","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.brs.2019.02.015_bib38","doi-asserted-by":"crossref","first-page":"21222","DOI":"10.1038\/srep21222","article-title":"BDNF-induced LTP is associated with rapid Arc\/Arg3.1-dependent enhancement in adult hippocampal neurogenesis","volume":"6","author":"Kuipers","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.brs.2019.02.015_bib39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.brs.2018.04.003","article-title":"Electroconvulsive seizures influence dendritic spine morphology and BDNF expression in a neuroendocrine model of depression","volume":"11","author":"Maynard","year":"2018","journal-title":"Brain stimulation"},{"issue":"12","key":"10.1016\/j.brs.2019.02.015_bib40","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hipo.22171","article-title":"Genetic fate mapping of type-1 stem cell-dependent increase in newborn hippocampal neurons after electroconvulsive seizures","volume":"23","author":"Weber","year":"2013","journal-title":"Hippocampus"},{"issue":"19","key":"10.1016\/j.brs.2019.02.015_bib41","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1074\/jbc.M116.720029","article-title":"Brain-derived neurotrophic factor in megakaryocytes","volume":"291","author":"Chacon-Fernandez","year":"2016","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.brs.2019.02.015_bib42","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1023\/A:1018940732550","article-title":"Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in\u00a0vivo using vector-mediated peptide drug delivery","volume":"11","author":"Pardridge","year":"1994","journal-title":"Pharmaceut Res"},{"issue":"12","key":"10.1016\/j.brs.2019.02.015_bib43","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.brs.2019.02.015_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0032-1306278","article-title":"A\u00a0study of brain and serum brain-derived neurotrophic factor protein in Wistar and Wistar-Kyoto rat strains after electroconvulsive stimulus","volume":"45","author":"Kyeremanteng","year":"2012","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.brs.2019.02.015_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.35","article-title":"Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study","volume":"7","author":"Chiarotti","year":"2017","journal-title":"Transl Psychiatry"},{"issue":"4","key":"10.1016\/j.brs.2019.02.015_bib46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/mp.2015.142","article-title":"Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment","volume":"22","author":"Alboni","year":"2017","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.brs.2019.02.015_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.brs.2018.05.011","article-title":"BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy","author":"Ryan","year":"2018","journal-title":"Brain stimulation"},{"issue":"8","key":"10.1016\/j.brs.2019.02.015_bib48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopsych.2018.05.017","article-title":"Volume of the human Hippocampus and clinical response following electroconvulsive therapy","volume":"84","author":"Oltedal","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.brs.2019.02.015_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainresbull.2014.04.005","article-title":"Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression","volume":"104","author":"Bilgen","year":"2014","journal-title":"Brain Res Bull"},{"issue":"15","key":"10.1016\/j.brs.2019.02.015_bib50","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jpsychires.2009.04.010","article-title":"Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis","volume":"43","author":"Fernandes","year":"2009","journal-title":"J\u00a0Psychiatr Res"},{"issue":"2","key":"10.1016\/j.brs.2019.02.015_bib51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000352013","article-title":"Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients","volume":"68","author":"Lin","year":"2013","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.brs.2019.02.015_bib52","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4088\/JCP.v68n0404","article-title":"Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression","volume":"68","author":"Marano","year":"2007","journal-title":"J\u00a0Clin Psychiatr"},{"issue":"9","key":"10.1016\/j.brs.2019.02.015_bib53","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jpsychires.2012.05.003","article-title":"Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level","volume":"46","author":"Elfving","year":"2012","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.brs.2019.02.015_bib54","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J\u00a0Affect Disord"},{"issue":"20","key":"10.1016\/j.brs.2019.02.015_bib55","first-page":"3886","article-title":"Effect of different anesthesia techniques on the serum brain-derived neurotrophic factor (BDNF) levels","volume":"19","author":"Ozer","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.brs.2019.02.015_bib56","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s11064-007-9586-4","article-title":"Plasma concentrations of brain-derived neurotrophic factor in patients undergoing minor surgery: a randomized controlled trial","volume":"33","author":"Vutskits","year":"2008","journal-title":"Neurochem Res"},{"issue":"2","key":"10.1016\/j.brs.2019.02.015_bib57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/bja\/aex103","article-title":"Association of intraoperative changes in brain-derived neurotrophic factor and postoperative delirium in older adults","volume":"119","author":"Wyrobek","year":"2017","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.brs.2019.02.015_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hipo.22670","article-title":"Electroconvulsive stimulation results in long-term survival of newly generated hippocampal neurons in rats","volume":"27","author":"Olesen","year":"2017","journal-title":"Hippocampus"}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X19300683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X19300683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:12:23Z","timestamp":1761833543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X19300683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1935861X19300683"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2019.02.015","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}